drugset / Trial / NCT02269306

Predictors of Ovarian Response During Clomiphene Citrate Ovulation Induction in Patients With Polycystic Ovary Syndrome

NCT02269306

NaSingle-groupOpen-label

Summary

The purpose of this study is to determine whether Visceral fat area and other criteria assessed during initial screening could predict the response to ovulation induction with clomiphene citrate (CC) in patients with polycystic ovary syndrome (PCOS).

Timeline

Start
2011-01
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Clomiphene Other / unclassified 50 mg
Subject Clomiphene Other / unclassified 100 mg
Subject Clomiphene Other / unclassified 150 mg

Indications